Literature DB >> 6319531

Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan.

R A Ezekowitz, R B Sim, M Hill, S Gordon.   

Abstract

We have examined the role of macrophage (M phi plasma membrane receptors for the cleaved third complement component (iC3b; CR3) and mannosyl, fucosyl terminated glycoproteins (MFR) in uptake of unopsonized zymosan. Monoclonal antibodies against CR3, M1/70 (Mac-1) and MO1, each inhibited approximately 50% of uptake of 125I-zymosan by murine and human M phi, respectively. Yeast mannan inhibited 0-50% of zymosan uptake in various M phi, in parallel with their expression of MFR. We demonstrated that M phi were the source of C3 in our assay and that the activity of other components of the complement system, namely a C3 convertase, factor I, and a factor I cofactor were also present in serum-free cultures of human monocytes. Macrophage C3 was deposited rapidly, within 10 min, on the zymosan particles and mediated binding, ingestion, and stimulation of superoxide release in BCG-activated and thioglycollate-elicited peritoneal M phi via CR3. Local secretion of complement proteins by M phi themselves can therefore opsonize pathogens and cells able to activate the alternative pathway and effect their destruction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319531      PMCID: PMC2187194          DOI: 10.1084/jem.159.1.244

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  45 in total

1.  Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity.

Authors:  G D Ross; J D Lambris; J A Cain; S L Newman
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

2.  The kinetics of antibody binding to membrane antigens in solution and at the cell surface.

Authors:  D W Mason; A F Williams
Journal:  Biochem J       Date:  1980-04-01       Impact factor: 3.857

Review 3.  Biosynthesis of the MHC-linked complement proteins (C2, C4 and factor B) by mononuclear phagocytes.

Authors:  H R Colten
Journal:  Mol Immunol       Date:  1982-10       Impact factor: 4.407

4.  Human complement (C3b) receptors defined by a mouse monoclonal antibody.

Authors:  J Gerdes; M Naiem; D Y Mason; H Stein
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

5.  Human peripheral blood monocyte-derived macrophages produce haemolytically active C3 in vitro.

Authors:  R C Strunk; K S Kunke; P C Giclas
Journal:  Immunology       Date:  1983-05       Impact factor: 7.397

6.  Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor.

Authors:  D I Beller; T A Springer; R D Schreiber
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

7.  Yeast mannans inhibit binding and phagocytosis of zymosan by mouse peritoneal macrophages.

Authors:  S S Sung; R S Nelson; S C Silverstein
Journal:  J Cell Biol       Date:  1983-01       Impact factor: 10.539

8.  Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors.

Authors:  M G Goodman; D E Chenoweth; W O Weigle
Journal:  J Exp Med       Date:  1982-09-01       Impact factor: 14.307

9.  Tumor-promoting phorbol esters stimulate C3b and C3b' receptor-mediated phagocytosis in cultured human monocytes.

Authors:  S D Wright; S C Silverstein
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

10.  Down-regulation of mannosyl receptor-mediated endocytosis and antigen F4/80 in bacillus Calmette-Guérin-activated mouse macrophages. Role of T lymphocytes and lymphokines.

Authors:  R A Ezekowitz; S Gordon
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more
  55 in total

1.  Episomal expression of specific sense and antisense mRNAs in Leishmania amazonensis: modulation of gp63 level in promastigotes and their infection of macrophages in vitro.

Authors:  D Q Chen; B K Kolli; N Yadava; H G Lu; A Gilman-Sachs; D A Peterson; K P Chang
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

2.  Stimulus-specific defect in the phagocytic pathways of annexin 1 null macrophages.

Authors:  Simon Yona; Julia C Buckingham; Mauro Perretti; Roderick J Flower
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

3.  Complement component C1q enhances invasion of human mononuclear phagocytes and fibroblasts by Trypanosoma cruzi trypomastigotes.

Authors:  M T Rimoldi; A J Tenner; D A Bobak; K A Joiner
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

4.  Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer.

Authors:  Mei Zhang; Liane Chun; Victor Sandoval; Hallie Graor; Jay Myers; Joseph Nthale; Peter Rauhe; Zachary Senders; Kevin Choong; Alex Y Huang; Julian Kim
Journal:  Oncoimmunology       Date:  2017-10-30       Impact factor: 8.110

5.  The intrinsic complement regulator decay-accelerating factor modulates the biological response to vascular injury.

Authors:  Masashi Sakuma; Toshifumi Morooka; Yunmei Wang; Can Shi; Kevin Croce; Huiyun Gao; Michael Strainic; M Edward Medof; Daniel I Simon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03-18       Impact factor: 8.311

6.  Monoclonal antibodies that recognize distinct epitopes of the macrophage type three complement receptor differ in their ability to inhibit binding of Leishmania promastigotes harvested at different phases of their growth cycle.

Authors:  A Cooper; H Rosen; J M Blackwell
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

7.  A continuous alveolar macrophage cell line: comparisons with freshly derived alveolar macrophages.

Authors:  R J Helmke; V F German; J A Mangos
Journal:  In Vitro Cell Dev Biol       Date:  1989-01

8.  Opsonin-independent phagocytosis of group B streptococci: role of complement receptor type three.

Authors:  J M Antal; J V Cunningham; K J Goodrum
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists.

Authors:  Haibin Huang; Gary R Ostroff; Chrono K Lee; Jennifer P Wang; Charles A Specht; Stuart M Levitz
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

10.  Novel adjuvant action of lipopolysaccharides that possess mannose homopolysaccharides as O-specific polysaccharides on immune responses to nonimmunogenic autoantigens in mice.

Authors:  T Yokochi; M Fukada; M Kawai; Y H Zhang; G Z Jiang; K Takahashi
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.